1
Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP
Condition(s):Lymphoma, Non-HodgkinLast Updated:May 1, 2013Unknown status
Emetics as an Intervention: 261 Clinical Trials, Page 1 of 27
Hide Studies Not Open or Pending
2
Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.
Condition(s):EmesisLast Updated:January 30, 2017Unknown status
3
Rescue Emetic Therapy for Children Having Elective Surgery
Condition(s):Post Operative Nausea and Vomiting; Rescue Emetic TherapyLast Updated:November 14, 2017Withdrawn
4
Relief Band as an Adjunct to Antiemetic Therapy in Patients Who Receive Mod to Highly Emetogenic Chemotherapy
Condition(s):Nausea; VomitingLast Updated:October 2, 2015Withdrawn
5
Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy
Condition(s):Chemotherapy Induced Nausea and VomitingLast Updated:January 19, 2015Completed
6
A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer
Condition(s):Non-small Cell Lung CancerLast Updated:September 1, 2020Completed
7
Emend for Multiple-day Emetogenic Chemotherapy
Condition(s):Nausea; VomitingLast Updated:August 4, 2021Completed
8
Prevalence of Anticipatory Nausea and Vomiting in Cancer Patients Exposed to Highly Emetogenic Chemotherapy
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:March 8, 2021Unknown status
9
Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs
Condition(s):Chemotherapy Induced Nausea and Vomiting Pediatric Cancer PatientsLast Updated:February 9, 2022Not yet recruiting
10
Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting
Condition(s):Nausea; VomitingLast Updated:March 17, 2010Unknown status